Bring  new hope to patients  by developing  the most innovative radioactive diagnostic and therapeutic products.

Suzhou Smart Nuclide Pharmaceutical Technology Company was founded in 2015, our aim is to provide innovative diagnostic and therapeutic radiopharmaceuticals for patients around the world. Our products focus on thyroid cancer, precision radioactive imaging and targeted radioligand therapy. Since its foundation, Smart Nuclide has raised over 200 million yuan with four rounds of venture capital investment.
XML 地图